APOD and Parkinson disease: CXB increases the survival of human dopaminergic cells in 6‐OHDA and paraquat (PQ)‐induced PD models, evidenced by increasing the expression of apolipoprotein D (APOD), TFEB and cathepsin D (CTSD), thereby overcoming the negative effects of neurotoxins on cell survival.210